Pay in 4 interest-free payments of $6.55 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Subscribe to reliable sources of regulatory updates
Peptides expected to return to legal compounding status include: BPC-157 - studied for tissue repair, gut healing, and inflammation reduction Thymosin Alpha-1 - an immune-modulating peptide used in infectious disease and oncology support TB-500 (Thymosin Beta-4) - studied for muscle repair, flexibility, and recovery CJC-1295 and Ipamorelin - growth hormone-releasing peptides supporting sleep, metabolism, and lean muscle AOD-9604 - a peptide fragment studied for fat metabolism Selank and Semax - neuropeptides studied for cognitive function and anxiety GHK-Cu - a copper peptide studied for wound healing and regeneration MOTS-C - a mitochondrial peptide studied for metabolic regulation Important: Category 1 reclassification is not the same as FDA approval
Rather than scar tissue limiting movement and function after an injury, TB-500 promotes the formation of healthy, flexible tissue
However, a 2021 study by Sun et al
US$ 25.57
US$ 29.57
US$ 27.44
US$ 22.38
US$ 22.24
US$ 25.13
US$ 25.33
US$ 27.39
US$ 29.80
